Personal profile
After a 2 year period of research in bladder and prostate cancer with Cancer Research UK, based at the Christie Hospital in Manchester, he gained the higher degree of MD. This was in targeted therapies in the treatment of muscle invasive bladder cancer, affiliated to the University of Manchester.
His higher specialist Urology training has been undertaken in the North West Deanery with specialist urological oncology surgical training throughout tertiary cancer centres (The Christie).
Mr Maddineni has also undertaken further training in laparoscopic radical bilateral nerve sparing prostatectomy at the Erasmus University in Brussels, Belgium, under the mentorship of one of Europe’s leading minimally invasive laparoscopic prostate cancer surgeons.
He was appointed as a Consultant Urological Surgeon at Mid Cheshire NHS Foundation Trust. Here, he was the Cancer Lead and subsequently became the Clinical Lead for the Urology department. He was involved with the successful amalgamation of urological cancer services with Stockport NHS Trust.
Relocating to Manchester, Mr Maddineni is now the lead in minimally invasive urological surgery at Salford Royal NHS Foundation Trust, one of the North West’s premier urological units and NHS Trusts. He mentors surgical trainees and fellow Consultants in minimally invasive surgical techniques. He is the Cancer Lead for Urological Surgery at the Trust.
He also practices at the Christie Hospital, one of Europe’s leading cancer treatment centres. As part of this, he provides robotic surgery to complex renal cancers for the population of Greater Manchester.
He is a member of the NHSE Prostate Cancer Clinical Expert Group, which is affiliated to Prostate Cancer UK, helping to guide the direction of prostate cancer management in England and Wales. He is also a member of the NCRI Renal Cancer Surgical Research Group which oversees clinical trials for renal cancer patients.
Mr Maddineni is the Clinical Lead for urological cancer services for Greater Manchester Cancer, the largest cancer network outside London. In this role he has innovated contemporary urological cancer services for Manchester over the last 5 years. As chair of the Urology pathway board for GM he is responsible for clinical oversight of cancer care and the introduction of multiple diagnostic and treatment initiatives for urological patients.
He has recently chaired the NHS England commissioned Vanguard task force reviewing prostate cancer diagnostics across England (working closely with colleagues from The Royal Marsden and UCLH). Through this group, NHS England is now implementing the use of MRI prostate scans to improve the diagnosis of prostate cancer. He now leads the implementation of this in Greater Manchester, with the recent introduction of the straight to MRI diagnostic prostate cancer pathway in the cancer network.
He has also introduced the latest prostate biopsy techniques to Manchester through his role as Implementation Lead for the Best Timed Prostate Pathway (#BTiPP). The latest techniques incorporate MRI scans and a new, safer and more accurate form of targeted prostate biopsy. Through the acquisition of NHSE Transformation funding he is now implementing both modalities across Manchester to vastly improve the patient experience of the suspected prostate cancer pathway.
Mr Maddineni is also the Chief of Surgery at the Northern Care Alliance, one of the biggest NHS Trusts in the North West of England. Here he is responsible for surgical services across 4 hospital sites, serving a population of over 1 million people.
